M-NSG

1. Shear stress governs hematopoietic stem cell fate to promote inflammation-induced aging
发表年份：2026 来源杂志：Nature Aging

2. FOSL1 Orchestrates Epigenetic Reprogramming of Anaplastic Thyroid Cancer and Suppresses Natural Killer Cell-Mediated Antitumor Immunity
发表年份：2026 来源杂志：CANCER RESEARCH

3. Structure–Activity-Driven Multicompartment Lipid Nanoparticles for Synergistic mRNA and siRNA Codelivery in Acute Myeloid Leukemia
发表年份：2026 来源杂志：Journal of the American Chemical Society

4. Apoptotic bodies derived from human umbilical cord mesenchymal stem cells improve recovery from myocardial infarction in swine
发表年份：2026 来源杂志：Autophagy

5. ZBTB21 Is a Dual Suppressor of Pyroptosis and MHC-I Antigen Presentation That Promotes Tumor Immune Evasion
发表年份：2026 来源杂志：Advanced Science

6. PD-L1-Binding Antigen Presenters: Redirecting Vaccine-Induced Antibodies for Cancer Immunotherapy
发表年份：2026 来源杂志：Advanced Science

7. Vessels encapsulating tumor clusters promote non-invasive metastasis of hepatocellular carcinoma by shaping an immunosuppressive microenvironment
发表年份：2026 来源杂志：JOURNAL OF CLINICAL INVESTIGATION

8. Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors
发表年份：2026 来源杂志：Science Advances

9. mRNA lipid-nanoparticle-mediated mitochondrial apoptosis augments adoptive T cell immunotherapy
发表年份：2026 来源杂志：Cell Reports Medicine

10. Targeting endosomal trafficking-mediated antigen escape to resensitize myeloma to CAR-T therapy
发表年份：2026 来源杂志：Journal for ImmunoTherapy of Cancer

11. A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer
发表年份：2026 来源杂志：Cell Reports Medicine

12. Targeting FGFR1-regulated SPP1 signaling repolarizes immunosuppressive macrophages and sensitizes Hepatocellular Carcinoma to anti-PD-1 therapy
发表年份：2026 来源杂志：CANCER LETTERS

13. USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination
发表年份：2026 来源杂志：International Journal of Biological Sciences

14. Unleashing T cell surveillance for the eradication of quiescent persister tumor cells resistant to neoadjuvant chemotherapy
发表年份：2026 来源杂志：DEVELOPMENTAL CELL

15. A shark VNAR-IL-15 fusion protein that suppresses TROP2+ tumor growth
发表年份：2026 来源杂志：INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

16. Silencing SFRP1 in bone mesenchymal stem cells alleviates pediatric B-ALL-driven bone loss by activating Wnt/β-catenin signaling
发表年份：2026 来源杂志：Journal of Orthopaedic Translation

17. Metabolic reinvigoration of NK cells by IL-21 enhances immunotherapy against MHC class I-deficient solid tumors
发表年份：2026 来源杂志：Cell Reports

18. Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
发表年份：2026 来源杂志：JOURNAL OF MEDICINAL CHEMISTRY

19. Halofuginone exerts broad-spectrum cytotoxic effects by regulating p-eIF2α-S100A8/A9-calcium signaling, inhibiting global protein synthesis, and reversing the resistance of idarubicin in acute myeloid leukemia
发表年份：2026 来源杂志：Chinese Medicine

20. Lycorine suppresses cell growth and attenuates stemness through PI3K/AKT pathway in ovarian cancer
发表年份：2026 来源杂志：BIOCHEMICAL PHARMACOLOGY

21. Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance
发表年份：2026 来源杂志：Cancer Drug Resistance

22. ERCC6L promotes cutaneous melanoma progression via PLK1-mediated aerobic glycolysis: Mechanisms and therapeutic implications
发表年份：2026 来源杂志：LIFE SCIENCES

23. A novel human acute myeloid leukemia cell line SDEY-AML1 with KMT2A: MLLT3, IKZF1: EVX1 fusions exhibits high tumorigenicity in NSG mice
发表年份：2026 来源杂志：Scientific Reports

24. RARG promotes gastric cancer progression by activating PMEPA1 transcription and Wnt/β-catenin signalling
发表年份：2026 来源杂志：CELLULAR SIGNALLING

25. Preclinical Evaluation of AHT-102, a CLDN18.2 × CD3 Bispecific Antibody: Pharmacokinetics, Anti-Tumor Efficacy, Tissue Distribution, and Safety Profile
发表年份：2026 来源杂志：DRUGS IN R&D

26. Construction of a novel B7H3 VHH-Fc antibody with potent antitumor activity and NK/T cell activation
发表年份：2026 来源杂志：PROTEIN EXPRESSION AND PURIFICATION

27. Cytosolic acetyl-coenzyme A is a signalling metabolite to control mitophagy
发表年份：2025 来源杂志：NATURE

28. SARDH in the 1-C metabolism sculpts the T-cell fate and serves as a potential cancer therapeutic target
发表年份：2025 来源杂志：Cellular & Molecular Immunology

29. TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis
发表年份：2025 来源杂志：CANCER RESEARCH

30. MEN1 Promotes Ferroptosis by Disrupting CD44 Alternative Splicing to Suppress Lung Cancer
发表年份：2025 来源杂志：CANCER RESEARCH

31. Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation
发表年份：2025 来源杂志：Nature Communications

32. USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination
发表年份：2025 来源杂志：Acta Pharmaceutica Sinica B

33. OX40–heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice
发表年份：2025 来源杂志：Science Translational Medicine

34. Prickle4 Drives Microenvironmental Remodeling and Resistance to Parp Inhibition in IDH-Mutant Glioma
发表年份：2025 来源杂志：Advanced Science

35. Chemotherapy-Mediated Induction of PD-L1 via SEI1 Facilitates Myeloma Immune Evasion
发表年份：2025 来源杂志：Advanced Science

36. DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR-JAK2-STAT3 Pathway
发表年份：2025 来源杂志：Advanced Science

37. SenExo-cCCT2 Reprograms Senescence Response and Anti-Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma
发表年份：2025 来源杂志：Advanced Science

38. An Engineered Probiotic Consortium Based on Quorum-Sensing for Colorectal Cancer Immunotherapy
发表年份：2025 来源杂志：Advanced Science

39. SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells
发表年份：2025 来源杂志：LEUKEMIA

40. Liquid-liquid phase separation of ZHX2 protects DLBCL cells against ferroptosis through induction of SLC3A2
发表年份：2025 来源杂志：LEUKEMIA

41. STING mediates increased self-renewal and lineage skewing in DNMT3A-mutated hematopoietic stem/progenitor cells
发表年份：2025 来源杂志：LEUKEMIA

42. 5-FU@HFn combined with decitabine induces pyroptosis and enhances antitumor immunotherapy for chronic myeloid leukemia
发表年份：2025 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

43. Asparaginase Enhances CAR-T Cell Antitumor Immunity by Asparagine Metabolic Reprogramming and Induction of Central Memory Phenotype in ALL
发表年份：2025 来源杂志：MOLECULAR THERAPY

44. BCL-2 mutant B7H6-CAR-T cells synergized with venetoclax for treating small cell lung cancer
发表年份：2025 来源杂志：Journal for ImmunoTherapy of Cancer

45. JMJD3 upregulates ALOX5 to drive malignancy and concomitant ferroptosis sensitivity in gastric cancer
发表年份：2025 来源杂志：Cell Death & Disease

46. Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5
发表年份：2025 来源杂志：Cell Death & Disease

47. UHRF1-mediated epigenetic reprogramming regulates glycolysis to promote progression of B-cell acute lymphoblastic leukemia
发表年份：2025 来源杂志：Cell Death & Disease

48. ULBP2 CAR-T cells enhance gastric cancer immunotherapy by inhibiting CAF activation
发表年份：2025 来源杂志：Cell Death & Disease

49. Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma
发表年份：2025 来源杂志：Cell Death & Disease

50. Tryptamine-Functionalized Lipid Nanocarriers Co-delivering SMO/BRD4 Inhibitors for Synergistic Medulloblastoma Therapy
发表年份：2025 来源杂志：Biomaterials Research

51. Ephrin A1 functions as a ligand of EGFR to promote EMT and metastasis in gastric cancer
发表年份：2025 来源杂志：EMBO JOURNAL

52. Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model
发表年份：2025 来源杂志：Cell Communication and Signaling

53. Retinoic acid enhances γδ T cell cytotoxicity in nasopharyngeal carcinoma by reversing immune exhaustion
发表年份：2025 来源杂志：Cell Communication and Signaling

54. Histone acetylation activated-IGF2BP3 regulates cyclin D1 mRNA stability to drive cell cycle transition and tumor progression of hepatocellular carcinoma
发表年份：2025 来源杂志：INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

55. Deoxypodophyllotoxin inhibited the growth of malignant pleural mesothelioma by inducing necroptosis and mitotic catastrophe
发表年份：2025 来源杂志：PHYTOMEDICINE

56. CBX5 loss drives Pl3Kδ inhibitor resistance in mantle cell lymphoma and propolis restores sensitivity by inducing CBX5-mediated ferroptosis
发表年份：2025 来源杂志：PHYTOMEDICINE

57. Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma
发表年份：2025 来源杂志：npj Precision Oncology

58. Activation of PERK/eIF2α/ATF4 signaling inhibits ERα expression in breast cancer
发表年份：2025 来源杂志：NEOPLASIA

59. T cell receptor-like antibody specifically targets and eliminates cells infected with cytomegalovirus
发表年份：2025 来源杂志：Journal of Translational Medicine

60. Microenvironmental β-TrCP negates amino acid transport to trigger CD8+ T cell exhaustion in human non-small cell lung cancer
发表年份：2025 来源杂志：Cell Reports

61. LAMP5 modulates IRF4 stability and nuclear transport: a critical mechanism in myeloma progression and therapy
发表年份：2025 来源杂志：ONCOGENE

62. KRT5high TP63-expressing urothelial basal cells act as a driver to bladder urothelium regeneration in rabbit
发表年份：2025 来源杂志：Stem Cell Research & Therapy

63. Metrnl protects intestinal barrier function by regulating tight junctions via the IKKβ/IκBα/NFκB/MLCK/MLC signaling pathway
发表年份：2025 来源杂志：Cell Death Discovery

64. High-glucose-associated YTHDC1 lactylation reduces the sensitivity of bladder cancer to enfortumab vedotin therapy
发表年份：2025 来源杂志：Cell Reports

65. ENPP1 governs the metabolic regulation of effector T cells in autoimmunity by detecting cytosolic mitochondrial DNA
发表年份：2025 来源杂志：Cell Reports

66. Discovery of P11–2: A Potent First-in-Class MNK1-Targeting PROTAC Degrader for the Treatment of Cancer
发表年份：2025 来源杂志：JOURNAL OF MEDICINAL CHEMISTRY

67. Deciphering the role of IGF2BP2 and PRMT5 in gallbladder cancer progression: insights from multi-omics analysis
发表年份：2025 来源杂志：BRITISH JOURNAL OF CANCER

68. The pronounced cytotoxic effects of chimeric antigen receptor T cells targeting B7-H3 in organoids and liver xenografts derived from colorectal cancer patients
发表年份：2025 来源杂志：BRITISH JOURNAL OF CANCER

69. Tumor-derived CD84 promotes growth of acute myeloid leukemia cells via regulating non-homologous DNA end joining pathway
发表年份：2025 来源杂志：MOLECULES AND CELLS

70. Coke Oven Emission Exposure Triggers Malignant Transformation of Lung Epithelial Cells by SFTA1P-Dependent Alteration of Acetyl-CoA Metabolism
发表年份：2025 来源杂志：Environment & Health

71. Targeted editing of CCL5 with CRISPR-Cas9 nanoparticles enhances breast cancer immunotherapy
发表年份：2025 来源杂志：APOPTOSIS

72. COL4A2 drives ECM remodeling and stiffness increasing to promote breast cancer metastasis via YAP signaling pathway in dECM induced models
发表年份：2025 来源杂志：Biomaterials Advances

73. Marine natural product Methyl mycophenolate inhibits gastric cancer growth through regulating p53 and the downstream pathways
发表年份：2025 来源杂志：Cancer Cell International

74. Chemical induction of ferroptosis through GPX4 inhibition: Rational Design of Triazole-Benzoxazine Hybrids for melanoma therapy
发表年份：2025 来源杂志：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

75. Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer
发表年份：2025 来源杂志：Frontiers in Immunology

76. High expression of CXCL13 predicts a favorable response to immunotherapy by upregulating CXCR5+CD8+ T-cell infiltration in gastric cancer
发表年份：2025 来源杂志：Frontiers in Immunology

77. Scalable Matrigel-Free Suspension Culture for Generating High-Quality Human Liver Ductal Organoids
发表年份：2025 来源杂志：CELL PROLIFERATION

78. Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
发表年份：2025 来源杂志：MOLECULAR CANCER THERAPEUTICS

79. Optimization of a Novel 2 + 2 BCMA × CD3 Bispecific Antibody for Minimized Cytokine Release and Potent Efficacy
发表年份：2025 来源杂志：MOLECULAR CANCER THERAPEUTICS

80. Targeting CHEK1: Ginsenosides-Rh2 and Cu2O@G-Rh2 nanoparticles in thyroid cancer
发表年份：2025 来源杂志：CELL BIOLOGY AND TOXICOLOGY

81. Targeted delivery of circPDHK1 siRNA via aptamer functionalized lipid nanoparticles inhibits ccRCC growth and migration
发表年份：2025 来源杂志：INTERNATIONAL JOURNAL OF PHARMACEUTICS

82. mRNA-laden lipid nanoparticle-enabled humanized CD19 CAR-T-cell engineering for the eradication of leukaemic cells
发表年份：2025 来源杂志：BRITISH JOURNAL OF HAEMATOLOGY

83. In vivo RNA-seq and infection model reveal the different infection and immune characteristics of B. pertussis strains in China
发表年份：2025 来源杂志：Frontiers in Cellular and Infection Microbiology

84. Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells
发表年份：2025 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

85. ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
发表年份：2025 来源杂志：Frontiers in Pharmacology

86. NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia
发表年份：2025 来源杂志：CANCER BIOLOGY & THERAPY

87. Motor neuron and pancreas homeobox 1 (MNX1) suppresses Triple Negative Breast Cancer (TNBC) cell phagocytosis by macrophage through CD24 signaling
发表年份：2025 来源杂志：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

88. CD9 antibody enhances the anti-leukemia efficacy of γδT cells in adult B cell acute lymphoblastic leukemia
发表年份：2025 来源杂志：iScience

89. Demethylzeylasteral alleviates myeloid leukemia through PERK/eIF2α/ATF4/CHOP-mediated cell apoptosis
发表年份：2025 来源杂志：Translational Cancer Research

90. Clinical functional proteomics of intercellular signalling in pancreatic cancer
发表年份：2024 来源杂志：NATURE

91. Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
发表年份：2024 来源杂志：CANCER CELL

92. Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
发表年份：2024 来源杂志：NATURE MATERIALS

93. An oncolytic virus–T cell chimera for cancer immunotherapy
发表年份：2024 来源杂志：NATURE BIOTECHNOLOGY

94. The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
发表年份：2024 来源杂志：Cancer Discovery

95. Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
发表年份：2024 来源杂志：Cell Metabolism

96. Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
发表年份：2024 来源杂志：Cell Metabolism

97. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway
发表年份：2024 来源杂志：Molecular Cancer

98. Photo-metallo-immunotherapy: Fabricating Chromium-Based Nanocomposites to Enhance CAR-T Cell Infiltration and Cytotoxicity against Solid Tumors
发表年份：2024 来源杂志：ADVANCED MATERIALS

99. An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity
发表年份：2024 来源杂志：ADVANCED MATERIALS

100. Enhanced engraftment of human haematopoietic stem cells via mechanical remodelling mediated by the corticotropin-releasing hormone
发表年份：2024 来源杂志：Nature Biomedical Engineering

101. Vasopressin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice
发表年份：2024 来源杂志：Cell Stem Cell

102. FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity
发表年份：2024 来源杂志：Nature Communications

103. Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors
发表年份：2024 来源杂志：Nature Communications

104. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
发表年份：2024 来源杂志：Nature Communications

105. Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy
发表年份：2024 来源杂志：Nature Communications

106. Tumor-derived miR-9-5p-loaded EVs regulate cholesterol homeostasis to promote breast cancer liver metastasis in mice
发表年份：2024 来源杂志：Nature Communications

107. Specific surface-modified iron oxide nanoparticles trigger complement-dependent innate and adaptive antileukaemia immunity
发表年份：2024 来源杂志：Nature Communications

108. Succinate dehydrogenase deficiency-driven succinate accumulation induces drug resistance in acute myeloid leukemia via ubiquitin-cullin regulation
发表年份：2024 来源杂志：Nature Communications

109. Split-design approach enhances the therapeutic efficacy of ligand-based CAR-T cells against multiple B-cell malignancies
发表年份：2024 来源杂志：Nature Communications

110. ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms
发表年份：2024 来源杂志：Autophagy

111. Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT-PD-L1 Axis
发表年份：2024 来源杂志：Advanced Science

112. Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development
发表年份：2024 来源杂志：Advanced Science

113. SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer
发表年份：2024 来源杂志：Advanced Science

114. SKAP1 Expression in Cancer Cells Enhances Colon Tumor Growth and Impairs Cytotoxic Immunity by Promoting Neutrophil Extracellular Trap Formation via the NFATc1/CXCL8 Axis
发表年份：2024 来源杂志：Advanced Science

115. A pan-KRAS degrader for the treatment of KRAS-mutant cancers
发表年份：2024 来源杂志：Cell Discovery

116. ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis
发表年份：2024 来源杂志：LEUKEMIA

117. Anagrelide and idarubicin combination induces GSDME-mediated pyroptosis as a potential therapy for high-PDE3A acute myeloid leukemia
发表年份：2024 来源杂志：LEUKEMIA

118. Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib
发表年份：2024 来源杂志：CANCER RESEARCH

119. Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma
发表年份：2024 来源杂志：CANCER RESEARCH

120. Adhesion GPCR ADGRE2 Maintains Proteostasis to Promote Progression in Acute Myeloid Leukemia
发表年份：2024 来源杂志：CANCER RESEARCH

121. PRDM16 Induces Methylation of FLT3 to Promote FLT3-ITD Signaling and Leukemia Progression
发表年份：2024 来源杂志：CANCER RESEARCH

122. HDAC6-dependent deacetylation of NGF dictates its ubiquitination and maintains primordial follicle dormancy
发表年份：2024 来源杂志：Theranostics

123. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease
发表年份：2024 来源杂志：Gut Microbes

124. Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
发表年份：2024 来源杂志：Cell Reports Medicine

125. Enhancer looping protein LDB1 modulates MYB expression in T-ALL cell lines in vitro by cooperating with master transcription factors
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

126. Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia
发表年份：2024 来源杂志：Journal of Advanced Research

127. Rationally designed BCR-ABL kinase inhibitors for improved leukemia treatment via covalent and pro-/dual-drug targeting strategies
发表年份：2024 来源杂志：Journal of Advanced Research

128. Targeting RBM39 through indisulam induced mis-splicing of mRNA to exert anti-cancer effects in T-cell acute lymphoblastic leukemia
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

129. LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

130. USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα
发表年份：2024 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

131. iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation
发表年份：2024 来源杂志：MedComm

132. Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
发表年份：2024 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

133. RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

134. ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasis
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

135. ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

136. Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response
发表年份：2024 来源杂志：Journal for ImmunoTherapy of Cancer

137. Nuclear receptor E75/NR1D2 promotes tumor malignant transformation by integrating Hippo and Notch pathways
发表年份：2024 来源杂志：EMBO JOURNAL

138. Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia
发表年份：2024 来源杂志：Cell Communication and Signaling

139. KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
发表年份：2024 来源杂志：International Journal of Biological Sciences

140. The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment
发表年份：2024 来源杂志：Cell Death & Disease

141. A novel LGALS1-depended and immune-associated fatty acid metabolism risk model in acute myeloid leukemia stem cells
发表年份：2024 来源杂志：Cell Death & Disease

142. EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification
发表年份：2024 来源杂志：JOURNAL OF AUTOIMMUNITY

143. Connexin 25 maintains self-renewal and functions of airway basal cells for airway regeneration
发表年份：2024 来源杂志：Stem Cell Research & Therapy

144. Human umbilical cord mesenchymal stem cell-based gene therapy for hemophilia B using scAAV-DJ/8-LP1-hFIXco transduction
发表年份：2024 来源杂志：Stem Cell Research & Therapy

145. Modulating autophagy to boost the antitumor efficacy of TROP2-directed antibody-drug conjugate in pancreatic cancer
发表年份：2024 来源杂志：BIOMEDICINE & PHARMACOTHERAPY

146. IGSF9 promotes tumor invasion and metastasis through GSK-3β/β-catenin mediated EMT in lung cancer
发表年份：2024 来源杂志：NEOPLASIA

147. TCF12-regulated GRB7 facilitates the HER2+ breast cancer progression by activating Notch1 signaling pathway
发表年份：2024 来源杂志：Journal of Translational Medicine

148. IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
发表年份：2024 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

149. Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC
发表年份：2024 来源杂志：CANCER GENE THERAPY

150. ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer
发表年份：2024 来源杂志：Translational Oncology

151. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS
发表年份：2024 来源杂志：EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

152. Single-cell RNA-sequencing reveals a profound immune cell response in human cytomegalovirus-infected humanized mice
发表年份：2024 来源杂志：VIROLOGICA SINICA

153. Generation of self-renewing neuromesodermal progenitors with neuronal and skeletal muscle bipotential from human embryonic stem cells
发表年份：2024 来源杂志：Cell Reports Methods

154. PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles
发表年份：2024 来源杂志：SCANDINAVIAN JOURNAL OF IMMUNOLOGY

155. Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer
发表年份：2024 来源杂志：Biomedicines

156. Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity
发表年份：2024 来源杂志：ACS Omega

157. FYB1-targeted modulation of CAPG promotes AML progression
发表年份：2024 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

158. The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia
发表年份：2024 来源杂志：ANNALS OF HEMATOLOGY

159. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
发表年份：2024 来源杂志：DNA AND CELL BIOLOGY

160. Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice
发表年份：2024 来源杂志：Journal of Gastrointestinal Oncology

161. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing
发表年份：2024 来源杂志：MOLECULAR THERAPY

162. Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification
发表年份：2024 来源杂志：PHARMACOLOGICAL RESEARCH

163. miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair
发表年份：2024 来源杂志：JACC-Basic to Translational Science

164. Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis
发表年份：2024 来源杂志：International Journal of Biological Sciences

165. LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
发表年份：2024 来源杂志：Cell Death & Disease

166. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
发表年份：2024 来源杂志：Cell Death & Disease

167. Small extracellular vesicle piR-hsa-30937 derived from pancreatic neuroendocrine neoplasms upregulates CD276 in macrophages to promote immune evasion
发表年份：2024 来源杂志：Cancer Immunology Research

168. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome
发表年份：2024 来源杂志：Cell Reports

169. Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation
发表年份：2024 来源杂志：Stem Cell Research & Therapy

170. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation
发表年份：2024 来源杂志：PHYTOMEDICINE

171. Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer
发表年份：2024 来源杂志：OncoImmunology

172. PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
发表年份：2024 来源杂志：Frontiers in Immunology

173. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib
发表年份：2024 来源杂志：BIOCHEMICAL PHARMACOLOGY

174. The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML
发表年份：2024 来源杂志：MOLECULAR CANCER THERAPEUTICS

175. TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas
发表年份：2024 来源杂志：LIFE SCIENCES

176. FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis
发表年份：2024 来源杂志：Communications Biology

177. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer
发表年份：2024 来源杂志：INTERNATIONAL JOURNAL OF ONCOLOGY

178. Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
发表年份：2024 来源杂志：EJNMMI Radiopharmacy and Chemistry

179. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
发表年份：2024 来源杂志：DNA AND CELL BIOLOGY

180. Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023-03-18 来源杂志：Molecular Cancer

181. A novel antidiuretic hormone governs tumour-induced renal dysfunction
发表年份：2023 来源杂志：NATURE

182. Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals
发表年份：2023 来源杂志：CELL

183. Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia
发表年份：2023 来源杂志：Signal Transduction and Targeted Therapy

184. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023 来源杂志：Molecular Cancer

185. Tumors evade immune cytotoxicity by altering the surface topology of NK cells
发表年份：2023 来源杂志：NATURE IMMUNOLOGY

186. Targeting UBE2T Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Regulating Pyrimidine Metabolism and Replication Stress
发表年份：2023 来源杂志：GASTROENTEROLOGY

187. Bone marrow immune cells respond to fluctuating nutritional stress to constrain weight regain
发表年份：2023 来源杂志：Cell Metabolism

188. The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation
发表年份：2023 来源杂志：Cellular & Molecular Immunology

189. STING is a cell-intrinsic metabolic checkpoint restricting aerobic glycolysis by targeting HK2
发表年份：2023 来源杂志：NATURE CELL BIOLOGY

190. Cyclosporine A-resistant CAR-T cells mediate antitumour immunity in the presence of allogeneic cells
发表年份：2023 来源杂志：Nature Communications

191. SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity
发表年份：2023 来源杂志：Nature Communications

192. Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia
发表年份：2023 来源杂志：Nature Communications

193. Sequence-based drug design as a concept in computational drug design
发表年份：2023 来源杂志：Nature Communications

194. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models
发表年份：2023 来源杂志：Nature Communications

195. Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors
发表年份：2023 来源杂志：Cancer Communications

196. Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins
发表年份：2023 来源杂志：Cancer Communications

197. Canagliflozin primes antitumor immunity by triggering PD-L1 degradation in endocytic recycling
发表年份：2023 来源杂志：JOURNAL OF CLINICAL INVESTIGATION

198. Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s
发表年份：2023 来源杂志：JOURNAL OF EXPERIMENTAL MEDICINE

199. CAR-Aptamers Enable Traceless Enrichment and Monitoring of CAR-Positive Cells and Overcome Tumor Immune Escape
发表年份：2023 来源杂志：Advanced Science

200. NIRF/PET imaging of γδ T cells via metabolic glycoengineering and bioorthogonal labeling
发表年份：2023 来源杂志：CHEMICAL ENGINEERING JOURNAL

201. Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq
发表年份：2023 来源杂志：Advanced Science

202. Targeted therapy of central nervous system acute lymphoblastic leukemia with an integrin α6-targeted self-assembling proapoptotic nanopeptide
发表年份：2023 来源杂志：Engineering

203. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
发表年份：2023 来源杂志：Gut Microbes

204. Transcription factor Nkx2-3 maintains the self-renewal of hematopoietic stem cells by regulating mitophagy
发表年份：2023 来源杂志：LEUKEMIA

205. TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability
发表年份：2023 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

206. Targeting the Immunoglobulin IGSF9 Enhances Antitumor T-cell Activity and Sensitivity to Anti–PD-1 Immunotherapy
发表年份：2023 来源杂志：CANCER RESEARCH

207. PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
发表年份：2023 来源杂志：CANCER RESEARCH

208. Faecalibacterium prausnitzii abrogates intestinal toxicity and promotes tumor immunity to increase the efficacy of dual CTLA-4 and PD-1 checkpoint blockade
发表年份：2023 来源杂志：CANCER RESEARCH

209. Targeted glycan degradation potentiates cellular immunotherapy for solid tumors
发表年份：2023 来源杂志：PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

210. Sitravatinib as a potent FLT3 inhibitor can overcome gilteritinib resistance in acute myeloid leukemia
发表年份：2023 来源杂志：Biomarker Research

211. TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
发表年份：2023 来源杂志：JOURNAL OF NANOBIOTECHNOLOGY

212. DNAJC10 maintains survival and self-renewal of leukemia stem cells through PERK branch of the unfolded protein response
发表年份：2023 来源杂志：HAEMATOLOGICA

213. Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function
发表年份：2023 来源杂志：CANCER LETTERS

214. Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia
发表年份：2023 来源杂志：PHARMACOLOGICAL RESEARCH

215. PARP inhibitor exerts an anti-tumor effect via LMO2 and synergizes with cisplatin in natural killer/T cell lymphoma
发表年份：2023 来源杂志：BMC Medicine

216. Alternative splicing of HOXB-AS3 underlie the promoting effect of nuclear m6A reader YTHDC1 on the self-renewal of leukemic stem cells in acute myeloid leukemia
发表年份：2023 来源杂志：INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

217. TGF-β blocking combined with photothermal therapy promote tumor targeted migration and long-term antitumor activity of CAR-T cells
发表年份：2023 来源杂志：Materials Today Bio

218. Bispecific antibody targeting both B7-H3 and PD-L1 exhibits superior antitumor activities
发表年份：2023 来源杂志：ACTA PHARMACOLOGICA SINICA

219. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
发表年份：2023 来源杂志：Stem Cell Research & Therapy

220. Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager
发表年份：2023 来源杂志：Frontiers in Immunology

221. SIGLEC10+ macrophages drive gastric cancer progression by suppressing CD8+ T cell function
发表年份：2023 来源杂志：CANCER IMMUNOLOGY IMMUNOTHERAPY

222. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma
发表年份：2023 来源杂志：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

223. CCL17 acts as an antitumor chemokine in micromilieu‐driven immune skewing
发表年份：2023 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

224. Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env+ cells in vivo
发表年份：2023 来源杂志：VIROLOGICA SINICA

225. Bruton tyrosine kinase inhibitors preserve anti-CD19 chimeric antigen receptor T-cell functionality and reprogram tumor micro-environment in B-cell lymphoma
发表年份：2023 来源杂志：CYTOTHERAPY

226. A second-generation CD38-CAR-T cell for the treatment of multiple myeloma
发表年份：2023 来源杂志：Cancer Medicine

227. Oxymatrine boosts hematopoietic regeneration by modulating MAPK/ERK phosphorylation after irradiation-induced hematopoietic injury
发表年份：2023 来源杂志：EXPERIMENTAL CELL RESEARCH

228. PD-L1 ImmunoPET on the basis of Avidin/Biotin pre-targeted cancer imaging
发表年份：2023 来源杂志：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

229. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份：2022-07-26 来源杂志：nature communications

230. A Chimeric Conjugate of Antibody and Programmable DNA Nanoassembly Smartly Activates T cell for Precise Cancer Cell Targeting
发表年份：2022-06-24 来源杂志：A Journal of the Gesellschaft Deutscher Chemiker

231. BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma
发表年份：2022 来源杂志：ADVANCED MATERIALS

232. Synthetic libraries of immune cells displaying a diverse repertoire of chimaeric antigen receptors as a potent cancer immunotherapy
发表年份：2022 来源杂志：Nature Biomedical Engineering

233. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份：2022 来源杂志：Nature Communications

234. Malfunction of airway basal stem cells plays a crucial role in pathophysiology of tracheobronchopathia osteoplastica
发表年份：2022 来源杂志：Nature Communications

235. Modeling Human Thyroid Development by Fetal Tissue-Derived Organoid Culture
发表年份：2022 来源杂志：Advanced Science

236. Inhibition of Calcium Signaling Prevents Exhaustion and Enhances Anti-Leukemia Efficacy of CAR-T Cells via SOCE-Calcineurin-NFAT and Glycolysis Pathways
发表年份：2022 来源杂志：Advanced Science

237. Nano-Biohybrid DNA Engager That Reprograms the T-Cell Receptor
发表年份：2022 来源杂志：Journal of the American Chemical Society

238. Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer
发表年份：2022 来源杂志：Science Advances

239. Heliangin acts as a covalent ligand of RPS2 that disrupts pre-rRNA metabolic processes in NPM1-mutated acute myeloid leukemia
发表年份：2022 来源杂志：Acta Pharmaceutica Sinica B

240. An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
发表年份：2022 来源杂志：MOLECULAR THERAPY

241. Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction
发表年份：2022 来源杂志：LEUKEMIA

242. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer
发表年份：2022 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

243. Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL
发表年份：2022 来源杂志：CELL DEATH AND DIFFERENTIATION

244. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography
发表年份：2022 来源杂志：EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

245. Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2
发表年份：2022 来源杂志：Cell Reports

246. Repurposing antiparasitic antimonials to noncovalently rescue temperature-sensitive p53 mutations
发表年份：2022 来源杂志：Cell Reports

247. Lenvatinib for effectively treating antiangiogenic drug-resistant nasopharyngeal carcinoma
发表年份：2022 来源杂志：Cell Death & Disease

248. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma
发表年份：2022 来源杂志：Cell Death & Disease

249. LncSIK1 enhanced the sensitivity of AML cells to retinoic acid by the E2F1/autophagy pathway
发表年份：2022 来源杂志：CELL PROLIFERATION

250. Gene therapy with B-cell maturation antigen/CD3 bispecific antibody encoding plasmid DNA for treating multiple myeloma
发表年份：2022 来源杂志：BRITISH JOURNAL OF HAEMATOLOGY

251. Anti-c-MET Fab-Grb2-Gab1 Fusion Protein-Mediated Interference of c-MET Signaling Pathway Induces Methuosis in Tumor Cells
发表年份：2022 来源杂志：INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

252. SLC35B4 Stabilizes c-MYC Protein by O-GlcNAcylation in HCC
发表年份：2022 来源杂志：Frontiers in Pharmacology

253. Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
发表年份：2022 来源杂志：Frontiers in Pharmacology

254. Large-cohort humanized NPI mice reconstituted with CD34+ hematopoietic stem cells are feasible for evaluating preclinical cancer immunotherapy
发表年份：2022 来源杂志：FASEB JOURNAL

255. Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response
发表年份：2022 来源杂志：Frontiers in Oncology

256. ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma
发表年份：2022 来源杂志：Frontiers in Oncology

257. LncRNA SNHG3 enhances BMI1 mRNA stability by binding and regulating c-MYC: Implications for the carcinogenic role of SNHG3 in bladder cancer
发表年份：2022 来源杂志：Cancer Medicine

258. Liver type 1 innate lymphoid cells develop locally via an interferon-γ–dependent loop
发表年份：2021 来源杂志：SCIENCE

259. A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
发表年份：2021 来源杂志：Science Translational Medicine

260. The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability
发表年份：2021 来源杂志：MOLECULAR CELL

261. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase
发表年份：2021 来源杂志：HEPATOLOGY

262. DMDRMR-Mediated Regulation of m6A-Modified CDK4 by m6A Reader IGF2BP3 Drives ccRCC Progression
发表年份：2021 来源杂志：CANCER RESEARCH

263. Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
发表年份：2021 来源杂志：CLINICAL CANCER RESEARCH

264. WSB1 regulates c-Myc expression through β-catenin signaling and forms a feedforward circuit
发表年份：2021 来源杂志：Acta Pharmaceutica Sinica B

265. TIGIT-Fc Promotes Antitumor Immunity
发表年份：2021 来源杂志：Cancer Immunology Research

266. FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53
发表年份：2021 来源杂志：ONCOGENE

267. Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
发表年份：2021 来源杂志：Frontiers in Immunology

268. Enhanced HSC-like cell generation from mouse pluripotent stem cells in a 3D induction system cocultured with stromal cells
发表年份：2021 来源杂志：Stem Cell Research & Therapy

269. Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection
发表年份：2021 来源杂志：Molecular Therapy-Methods & Clinical Development

270. Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
发表年份：2021 来源杂志：Cancers

271. A novel and effective approach to generate germline-like monoclonal antibodies by integration of phage and mammalian cell display platforms
发表年份：2021 来源杂志：ACTA PHARMACOLOGICA SINICA

272. Establishment of Functional Liver Spheroids From Human Hepatocyte-Derived Liver Progenitor-Like Cells for Cell Therapy
发表年份：2021 来源杂志：Frontiers in Bioengineering and Biotechnology

273. Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy
发表年份：2021 来源杂志：Frontiers in Pharmacology

274. RXR Negatively Regulates Ex Vivo Expansion of Human Cord Blood Hematopoietic Stem and Progenitor Cells
发表年份：2021 来源杂志：Stem Cell Reviews and Reports

275. Demethyleneberberine induces cell cycle arrest and cellular senescence of NSCLC cells via c-Myc/HIF-1α pathway
发表年份：2021 来源杂志：PHYTOMEDICINE

276. CoFe2O4-Quantum Dots for Synergistic Photothermal/Photodynamic Therapy of Non-small-Cell Lung Cancer Via Triggering Apoptosis by Regulating PI3K/AKT Pathway
发表年份：2021 来源杂志：Nanoscale Research Letters

277. NGF nanoparticles enhance the potency of transplanted human umbilical cord mesenchymal stem cells for myocardial repair
发表年份：2021 来源杂志：AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

278. Transplantation of GMP-grade human iPSC-derived retinal pigment epithelial cells in rodent model: the first pre-clinical study for safety and efficacy in China
发表年份：2021 来源杂志：Annals of Translational Medicine

279. Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics
发表年份：2020 来源杂志：CELL

280. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation
发表年份：2020 来源杂志：Nature Communications

281. Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins
发表年份：2020 来源杂志：STEM CELLS

282. 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
发表年份：2020 来源杂志：Frontiers in Immunology

283. Arming Anti-EGFRvIII CAR-T With TGFβ Trap Improves Antitumor Efficacy in Glioma Mouse Models
发表年份：2020 来源杂志：Frontiers in Oncology

284. The Interleukin-33/ST2 axis promotes glioma mesenchymal transition, stemness and TMZ resistance via JNK activation
发表年份：2020 来源杂志：Aging-US

285. Lgr5 maintains stemness and regulates cell property in nasopharyngeal carcinoma through Wnt/β-catenin signaling pathway
发表年份：2020 来源杂志：Stem Cell Research

286. Peptide Self-Assembly Nanoparticles Loaded with Panobinostat to Activate Latent Human Immunodeficiency Virus
发表年份：2019-05-01 来源杂志：J Biomed Nanotechnol